ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,266.05
0.74%
Dow Jones
38,894.34
0.15%
Gold vs US Dollar
2,358.83
1.26%
Brent Oil
85.015
0.38%
Bitcoin
64,833.21
-0.19%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Eupraxia Pharmaceuticals Inc (EPRX) Share Price

EPRX Eupraxia Pharmaceuticals Inc

3.61
0.14 (4.03%)
Last Updated: 15:27:08
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Eupraxia Pharmaceuticals Inc TSX:EPRX Toronto Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.14 4.03 3.61 3.56 3.64 3.61 3.50 3.5 6,300 14:27:08   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -28.22M -1.0344 -3.44 97.12M
 Type  Size  Price  Time  Units 
  100 3.61 14:27:08 CAD
 
Recent News
DateTimeSource
HeadlineMore EPRX News
06/06/202422:00PRNUSEupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
06/06/202422:00PRNCAEupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
05/06/202412:00PRNUSEupraxia Pharmaceuticals to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024
05/06/202412:00PRNCAEupraxia Pharmaceuticals to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024
23/05/202422:00PRNCAEupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
23/05/202422:00PRNUSEupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
22/05/202412:00PRNUSEupraxia Pharmaceuticals to Host Virtual KOL Event on EP-104GI Clinical Development Program for Eosinophilic Esophagitis ("EoE") on May 29, 2024
Period
Draw mode
Data Downloads for EPRX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Eupraxia Pharmaceuticals Inc Articles